P. Chikoti

464 total citations
8 papers, 370 citations indexed

About

P. Chikoti is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, P. Chikoti has authored 8 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in P. Chikoti's work include Immunotherapy and Immune Responses (6 papers), Virus-based gene therapy research (4 papers) and vaccines and immunoinformatics approaches (2 papers). P. Chikoti is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Virus-based gene therapy research (4 papers) and vaccines and immunoinformatics approaches (2 papers). P. Chikoti collaborates with scholars based in United Kingdom, United States and Kenya. P. Chikoti's co-authors include William Shingler, Richard Harrop, Susan M. Kingsman, Noel Drury, Stuart Naylor, Miles W. Carroll, Irina Redchenko, Nicola Winstone, Job J. Bwayo and Edmund G. Wee and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of General Virology.

In The Last Decade

P. Chikoti

8 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Chikoti United Kingdom	6	224	133	129	114	89	8	370
Cristina Jemma Italy	8	245 1.1×	94 0.7×	83 0.6×	150 1.3×	63 0.7×	13	431
Noel Drury United Kingdom	7	276 1.2×	98 0.7×	46 0.4×	224 2.0×	83 0.9×	11	405
Daniel T. Claiborne United States	12	181 0.8×	128 1.0×	216 1.7×	97 0.9×	67 0.8×	27	439
Jonathan Hare United States	7	75 0.3×	143 1.1×	102 0.8×	64 0.6×	62 0.7×	30	321
Siew Yen Chong United States	7	264 1.2×	98 0.7×	97 0.8×	71 0.6×	139 1.6×	12	415
Michael I. Zimmer United States	11	571 2.5×	180 1.4×	76 0.6×	109 1.0×	87 1.0×	11	722
Ron Tha Hla Australia	6	210 0.9×	103 0.8×	62 0.5×	50 0.4×	114 1.3×	7	362
Matija Peterlin United States	8	321 1.4×	136 1.0×	115 0.9×	97 0.9×	52 0.6×	8	497
Christopher J. Hartmann United States	8	122 0.5×	243 1.8×	320 2.5×	104 0.9×	255 2.9×	9	562
Kailan Sierra-Davidson United States	3	197 0.9×	71 0.5×	136 1.1×	103 0.9×	61 0.7×	9	356

Countries citing papers authored by P. Chikoti

Since Specialization

Citations

This map shows the geographic impact of P. Chikoti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Chikoti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Chikoti more than expected).

Fields of papers citing papers by P. Chikoti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Chikoti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Chikoti. The network helps show where P. Chikoti may publish in the future.

Co-authorship network of co-authors of P. Chikoti

This figure shows the co-authorship network connecting the top 25 collaborators of P. Chikoti. A scholar is included among the top collaborators of P. Chikoti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Chikoti. P. Chikoti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Hawkins, Robert E., Fiona Thistlethwaite, Noel Drury, et al.. (2009). Vaccination of Patients With Metastatic Renal Cancer With Modified Vaccinia Ankara Encoding the Tumor Antigen 5T4 (TroVax) Given Alongside Interferon-α. Journal of Immunotherapy. 32(4). 424–429. 36 indexed citations

Shingler, William, P. Chikoti, Susan M. Kingsman, & Richard Harrop. (2008). Identification and functional validation of MHC class I epitopes in the tumor-associated antigen 5T4. International Immunology. 20(8). 1057–1066. 22 indexed citations

Harrop, Richard, Fiona Thistlethwaite, Noel Drury, et al.. (2008). Vaccination of renal cell cancer patients with TroVax (modified vaccinia Ankara delivering the tumor antigen 5T4) plus IFNα: A phase II trial. Journal of Clinical Oncology. 26(15_suppl). 3053–3053. 4 indexed citations

Hernandez-McClain, Joan, J. P. Willis, Richard Harrop, et al.. (2007). Activity of MVA 5T4 alone or in combination with either interleukin-2 (IL-2) or interferon-α (IFN) in patients (Pts) with metastatic renal cell cancer (MRCC). Journal of Clinical Oncology. 25(18_suppl). 3069–3069. 6 indexed citations

Harrop, Richard, Noel Drury, William Shingler, et al.. (2007). Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses. Cancer Immunology Immunotherapy. 57(7). 977–986. 63 indexed citations

Harrop, Richard, Noel Drury, William Shingler, et al.. (2007). Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Encoding the Tumor Antigen 5T4 (TroVax) Given Alongside Chemotherapy Induces Potent Immune Responses. Clinical Cancer Research. 13(15). 4487–4494. 73 indexed citations

Amato, R. J., J. P. Willis, Megan McDonald, et al.. (2006). 117 POSTER Activity of MVA 5T4 alone or in combination with either Interleukin-2 (IL-2), Interferon-alpha (IFN), or Sunitinib in patients (Pts) with Metastatic Renal Cell Cancer (MRCC). European Journal of Cancer Supplements. 4(12). 39–39. 1 indexed citations

Mwau, Matilu, Julian Sutton, P. Chikoti, et al.. (2004). A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. Journal of General Virology. 85(4). 911–919. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact